MENU
+Compare
PJP
ETF ticker: NYSE ARCA
AS OF
Sep 16, 03:17 PM (EDT)
Price
$90.86
Change
-$0.05 (-0.05%)
Net Assets
263.97M

PJP stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index... Show more

Category: #Health
PJP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for PJP with price predictions
Sep 15, 2025

PJP sees MACD Histogram crosses below signal line

PJP saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 08, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PJP moved out of overbought territory on September 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where PJP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PJP as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PJP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PJP broke above its upper Bollinger Band on September 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The 50-day moving average for PJP moved above the 200-day moving average on August 19, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PJP advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 250 cases where PJP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Pharmaceuticals ETF ETF is 86.28B. The market cap for tickers in the group ranges from 810.28M to 670.72B. LLY holds the highest valuation in this group at 670.72B. The lowest valued company is GERN at 810.28M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Pharmaceuticals ETF ETF was 5%. For the same ETF, the average monthly price growth was 27%, and the average quarterly price growth was 69%. TVTX experienced the highest price growth at 9%, while TARS experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Invesco Pharmaceuticals ETF ETF was -5%. For the same stocks of the ETF, the average monthly volume growth was 2% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 67
Price Growth Rating: 53
SMR Rating: 63
Profit Risk Rating: 63
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
PJP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Powershares Exchange Traded Fund Trust227 E Prairie AveWheaton
Phone
N/A
Web
www.invescopowershares.com